<SEC-DOCUMENT>0000898432-25-000189.txt : 20250317
<SEC-HEADER>0000898432-25-000189.hdr.sgml : 20250317
<ACCEPTANCE-DATETIME>20250317164503
ACCESSION NUMBER:		0000898432-25-000189
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250317
DATE AS OF CHANGE:		20250317

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amneal Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001723128
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90473
		FILM NUMBER:		25745226

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		(908) 947-3120

	MAIL ADDRESS:	
		STREET 1:		400 CROSSING BOULEVARD
		STREET 2:		3RD FLOOR
		CITY:			BRIDGEWATER
		STATE:			NJ
		ZIP:			08807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Atlas Holdings, Inc.
		DATE OF NAME CHANGE:	20171117

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Patel Tushar Bhikhubhai
		CENTRAL INDEX KEY:			0001745375
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		C/O TARSADIA INVESTMENTS
		STREET 2:		520 NEWPORT CENTER DRIVE, 21ST FLOOR
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13D/A</submissionType>
<previousAccessionNumber>0000898432-24-000401</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001745375</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>5</amendmentNo>
<securitiesClassTitle>Class A Common Stock, par value $0.01</securitiesClassTitle>
<dateOfEvent>03/14/2025</dateOfEvent>
<previouslyFiledFlag>false</previouslyFiledFlag>
<issuerInfo>
<issuerCIK>0001723128</issuerCIK>
<issuerCUSIP>03168L105</issuerCUSIP>
<issuerName>Amneal Pharmaceuticals, Inc.</issuerName>
<address>
<com:street1>400 Crossing Blvd</com:street1>
<com:city>Bridgewater</com:city>
<com:stateOrCountry>NJ</com:stateOrCountry>
<com:zipCode>08807</com:zipCode>
</address>
</issuerInfo>
<authorizedPersons>
<notificationInfo>
<personName>Edward Coss</personName>
<personPhoneNum>(949) 610-8022</personPhoneNum>
<personAddress>
<com:street1>520 Newport Center Drive</com:street1>
<com:street2>21th Floor</com:street2>
<com:city>Newport Beach</com:city>
<com:stateOrCountry>CA</com:stateOrCountry>
<com:zipCode>92660</com:zipCode>
</personAddress>
</notificationInfo>
</authorizedPersons>
</coverPageHeader>
<reportingPersons>
<reportingPersonInfo>
<reportingPersonCIK>0001745375</reportingPersonCIK>
<reportingPersonName>Patel Tushar Bhikhubhai</reportingPersonName>
<memberOfGroup>a</memberOfGroup>
<fundType>OO</fundType>
<citizenshipOrOrganization>X1</citizenshipOrOrganization>
<soleVotingPower>48578209</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>48578209</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
<aggregateAmountOwned>48578209</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>15.7</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<commentContent>The percentage of ownership of the Class A Common Stock by the Reporting Person presented in this Statement is based on 309,966,341 shares of Class A Common Stock outstanding as of February 14, 2025, as reported in the Issuer's Annual Report on Form 10-K filed on February 28, 2025.</commentContent>
</reportingPersonInfo>
</reportingPersons>
<items1To7>
<item1>
<securityTitle>Class A Common Stock, par value $0.01</securityTitle>
<issuerName>Amneal Pharmaceuticals, Inc.</issuerName>
<issuerPrincipalAddress>
<com:street1>400 Crossing Blvd</com:street1>
<com:city>Bridgewater</com:city>
<com:stateOrCountry>NJ</com:stateOrCountry>
<com:zipCode>08807</com:zipCode>
</issuerPrincipalAddress>
</item1>
<item4>
<transactionPurpose>On March 14, 2025, the Reporting Person caused TI SIE 2, LLC, a Delaware limited liability company ("TI SIE 2"), the sole member of which is a trust controlled by the Reporting Person, to sell 5,000,000 shares of Class A Common Stock in a block trade to Citigroup Global Markets Inc., at a price per share of $8.35.  The purpose of this transaction was to obtain liquidity for a portion of the shares of Class A Common Stock beneficially owned by the Reporting Person.</transactionPurpose>
</item4>
<item5>
<numberOfShares>The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by the Reporting Person, as well as the number of shares of Class A Common Stock as to which the Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition, as of the date hereof, based on 309,966,341 shares of Class A Common Stock outstanding as of February 14, 2025, as reported in the Issuer's Annual Report on Form 10-K filed on February 28, 2025:&#13;
&#13;
Reporting Person - Tushar Patel&#13;
Amount Beneficially Owned - 48,578,209&#13;
Percent of Class - 15.7&#13;
Sole power to vote or to direct the vote - 48,578,209&#13;
Shared power to vote or to direct the vote - 0&#13;
Sole power to dispose or to direct the disposition - 48,578,209&#13;
Shared power to dispose or to direct the disposition - 0&#13;
&#13;
The Reporting Person may be deemed to beneficially own 48,578,209 shares of Class A Common Stock held of record by TI SIE 2.</numberOfShares>
<transactionDesc>The information set forth in Item 4 of this Amendment No. 5 is incorporated by reference herein.</transactionDesc>
<listOfShareholders>None.</listOfShareholders>
<date5PercentOwnership>Not applicable.</date5PercentOwnership>
</item5>
</items1To7>
<signatureInfo>
<signaturePerson>
<signatureReportingPerson>Patel Tushar Bhikhubhai</signatureReportingPerson>
<signatureDetails>
<signature>Tushar Patel</signature>
<title>Patel Tushar Bhikhubhai</title>
<date>03/17/2025</date>
</signatureDetails>
</signaturePerson>
</signatureInfo>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
